Citrate Anticoagulation in Continuous Renal Replacement Therapy: Multicenter PICU Study of Filter-Related Outcomes
Citrate anticoagulation for CRRT is an option for children. Choosing an initial CID greater than or equal to 2.7 mmol/L-bf provides longer EFL but with the associated potential of citrate accumulation. Further studies are needed on initial CID and duration of EFL.
Authors
- Esra Şevketoğlu (ORCID: https://orcid.org/0000-0002-8330-2877)
- Ebru Atike Ongun (ORCID: https://orcid.org/0000-0002-1248-8635)
- Edin Botan (ORCID: https://orcid.org/0000-0003-4586-1595)
- Hacer Ucmak
- İlknur Tolunay (ORCID: https://orcid.org/0000-0002-3454-8483)
- Hasan Serdar Kıhtır (ORCID: https://orcid.org/0000-0003-0120-8711)
- Muhterem Duyu (ORCID: https://orcid.org/0000-0001-7892-2927)
- Dinçer Yıldızdaş (ORCID: https://orcid.org/0000-0003-0739-5108)
- Emrah Gün (ORCID: https://orcid.org/0000-0001-7337-0190)
- Tanıl Kendirli (ORCID: https://orcid.org/0000-0001-9458-2803)
- Faruk Ekıncı (ORCID: https://orcid.org/0000-0001-6675-3150)
- Ayşe Aşık
- Mehmet E. Mementoglu
Institutions
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
Publication Details
- Journal
- Pediatric Critical Care Medicine
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1097/pcc.0000000000003661
- Citations
- 4
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 1.36